Registered Number.. SC492045 Scotland FIBROMYALGIA ACTION UK Report of Ihe Directors and Unaudited Financial Statements Perlod of accounts Start dato: 01 December 2023 End date: 30 November 2024
FIBROMYALGIA ACTION UK Contents Page For the year ended 30 November 2024 Company infomiation Directors. report Accounlanls. report Income slatement Statemenl of financial position Noles to Ihe financial stalements 10 Detailed Income Stalement 14 2of15
FIBROMYALGIA ACTION UK Company Information For the year ended 30 November 2024 Dlrectors Jan6l Horton Des Quinn Helen Margaret Watts Tracy Wheeler Registered Number SC492045 Registered Offlce 12 Seedhill Road 3006 Mile End Mill Paisley PA1 1JS Accountants Josh Bolham Tax & Accounting Servlces Ltd Archer House Britland Estate Northbourne Road Eastbourne BN22 8PW 3of15
FIBROMYALGIA ACTION UK Directors, Report For the year ended 30 November 2024 Dlrector's report and financial statements The directors present hislherltheir annual report and the financial slatements for the year ended 30 November 2024. Principal activities Principal activity of the company during Ihe financial year was of Fibromyalgia awareness. Dlrectors The directors who served the company Ihroughoul Ihe year were as follows: Janet Horton Des Quinn Helen Margaret Watts Tracy Wheeler Statement of dlrectors, responslbllltles The directors are responsible for preparing the directors, report and the financial statements in accordance with applicable law and regulallons and in accordance with United Kingdom Generally Accepted Accounting Practice. Company law requires the directors to prepar8 financial statements for each financial year. Under that law the directors hava 8lected to prepare the financial slalements in accordanc8 with United Kingdom Generally Accepted Accounling Practice (United Kingdorn Accounting Standards and applicable law). Under company law lh8 diiectors must not approve tho financial statemgnts unl8SS they are satisfied that they give a Irue and lair view of Ihe state of affairs of the company and the profit or loss of the company for Ihat period. In preparing these financial statements, the direclors are required to . select sultable accounting policies and Ihen apply them consistently make judgements and accounting eslimales that are reasonable and prudent state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements and prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business. The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with tha Companies Act 2006. The direclors are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. The directors are responsible for the maintenance and integrity of the corporate and financial information included on the company's website. Legislation in the United Kingdom, governing the preparation and dissemination of financial statements. may differ from legislation in other jurisdictions 4of15
FIBROMYALGIA ACTION UK Directors. Report For the year ended 30 November 2024 This report was approved by the board and signed on its behalf by: Des Quinn Director Date approved.. 17 June 2025 5of15
FIBROMYALGIA ACTION UK Accountants, Report For the year ended 30 November 2024 Accountant's report You consider that the company is exempt from an audit for the year ended 30 November 2024 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respecl to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year. In accordance wilh your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Compiehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounling records of the company and on tho basis of information and explanalions you have given to us. We have not carried out an audit or any other review. and consequently we do not express any opinion on these accounts. Josh Botham Tax & Accounting Services Ltd 30 November 2024 Josh Both8m T8x & Accounting Services Ltd Archer House Britland Estate Northbourne Road Eastbourne BN22 8PW 17 June 2025 6of15
FIBROMYALGIAACTION UK Income Statement For the year ended 30 November 2024 Notes 2024 2023 Turnover 204,749 491,497 Cost of sales (1.325) {3,374) 488,123 Gross profit Selling and distribution cosls Administrative expenses Operatlng profit Profltl{Loss) on ordinary actlvltles before taxatlon Tax on profit on ordinary activities ProflLI(Loss) for the financial year 203,424 (329) (114,831) 88,264 (702) (103,073) 384,348 88,264 (579) 87,685 384,348 384,348 7of15
FIBROMYALGIA ACTION UK Statement of Financial Position As at 30 November 2024 Notes 2024 2023 Fixed assets Tangible fixed assets 589 589 589 589 Current assets Stocks 2.420 2,420 Debtors.. amounts falling due within one year Cash at bank and in hand 4,055 793,156 1,248 707,447 799,631 (3,156) 796,475 711,115 (2,325) 708,790 Credltors: amount falllng due wlthln on8 year Net current assets Total assets less current Ilabllltles 797,064 709,379 Net assets 797,064 709,379 Capltal and reserves Profit and loss account 797,064 709,379 Shareholders, funds 797,064 709,379 For the year ended 30 November 2024 the company was enlilled to exemption from audit under section 477 of the Companles Acl 2006 relating to small companies. Dlrectors, responsibilities: 1. The members have not required the company to obtain an audit of its accounts for th6 year in question in accordance with section 476. 2. The directors acknowledge Iheir responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These financial statements have been prepared in accordance with the provisions applicable to Gompanies subject to the small companies regime. 8of15
FIBROMYALGIA ACTION UK Statement of Financial Position As at 30 November 2024 The financial statements were approved by the board of directors on 17 June 2025 and were signed on its b8half b Des Quinn Director 9of15
FIBROMYALGIA ACTION UK Notes to the Financial Statements For the year ended 30 November 2024 General Informatlon Fibromyalgia Action UK is a private company, limited by shares, registered in Scotland, registration number SC492045, registration address 12 Seedhill Road, 3006 Mile End Mill, Paisley, PA1 1 JS. The presentation currency is £ slerling. 1. Accounting policies Slgnlflcant accountlng pollcles statement of compliance These financial statements have been prepared in compliance with FRS 102 - The Financial Reporting Standard applicable in the UK and Republic of Ireland and th8 Companies Act 2006. Basls of praparatlon The financial statements have been prepared under Ihe historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies. The financial statements are prepared in sterling which is the functional curr8ncy of th8 company, Group accounts The company is a parent company subject to the small companies regime. The company and its subsidiary comprise a small group. The company has. Iherefore. taken advantage of the option provided by section 398 of the Companies Act 2006 not to prepare group accounts, Turnover Turnover comprises the invoiced value of goods and seNices supplied by the company, net of Value Added Tax and trade discounts. Governmant grants Government grants received are crediled lo deferred income. Grants towards capital expenditure are released to the income statemenl over the expected useful life of the assets. Grants received towards revenue expenditure are released lo the income statement as the related expenditure is incurred. Operatlng lease rentals Rentals payable under operating leases aro charged against income on a straight line basis over the lease term. Research and development expenditure Research and development expenditure is charged to the income statement in the period in which it is incurred. 10of15
FIBROMYALGIA ACTION UK Notes to the Financial Statements For the year ended 30 November 2024 Foraign currencles Monetary assets and liabilities denominated in foreign currencies ar8 translated into sterling at the rate of exchange ruling at the statement of financial position date. Transactions in foreign currencies are recorded at the rate ruling at the date of the transaction. All foreign exchange differences are included to Ihe income statement. Proference dividends Where preferenco shares are classed as liabilities rather than equity any preference dividends paid are included in interest payable and similar charges within the income statement. Tangible fixed assets Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreclation and any provision for impairment. Depreciation is provided al rates calculated to write off the cost or valuatlon of fixed assets, less their estimated residual value, over their expected useful lives on the following basis: Fixtures and Fittings 4 Straight Llne Stocks Stocks are valued at the lower of cost and nel realisable value after making due allowanc8 for obsolete and slow moving items. Cost includes all direcl cosls and an appropriate proportion of fixgd and variable overheads. 2. Operating profiU{Ioss) 2024 2023 The operating profit is slaled after charglng: Operating leases 329 702 3. Average number of employees Average number of employees during the year was 4 (2023 . 4). 4. Tax on proflt on ordlnary acllvltles 2024 2023 UK Corporation Tax 579 579 11of15
FIBROMYALGIA ACTION UK Notes to the Financial Statements For the year ended 30 November 2024 5. Tangible fixed assets Cost or valuation Fixtures and Fittings Total At 01 December 2023 5,215 5,215 Addltions Disposals At 30 November 2024 Depraclatlon At 01 December 2023 Charge for year On disposals At 30 November 2024 Net book values Closing balance as at 30 November 2024 Opening balance as at 01 December 2023 5,215 5,215 4,626 4,626 4,626 4,626 589 589 589 589 6. Stocks 2024 2023 Stocks 2,420 2,420 2,420 2,420 7. Debtors: amounts falllng duè within one year 2024 2023 Trade Debtors Prapayments & Accrued Income PAYE & Social Security {2) 1,248 2,809 4,055 1,248 1,248 12of15
FIBROMYALGIA ACTION UK Notes to the Financial Statements For the year ended 30 November 2024 8. Creditors: amount falllng due wlthln one year 2024 2023 Trade Creditors PAYE & Social Securily Accrued Expenses Other Creditors Wages & Salaries Control Account 2,654 1,572 350 403 350 403 (251) 3,156 2,325 9. Proflt and loss account 2024 Balance at 01 December 2023 Profit for the year Balance at 30 November 2024 709,379 87,685 797,064 13of15
FIBROMYALGIA ACTION UK Detailed Income Statement For the year ended 30 November 2024 2024 2023 Turnover Bank Interest 127 3,140 80,002 553 Donations Recieved 138,863 377 Payroll Income Charities Aid Foundation 1.728 62,884 770 512 Legacles Other Income 393,000 14,290 491,497 204,749 Cost of sales Purchases Other Direct Costs 473 1,325 2,901 {1,325) 203,424 (3,374) 488,123 Gross profit Selllng and dlstrlbutlon costs Operating Lease Charges - Planl & Equipment 329 702 (329) (702) Admlnlstratlvo expenses Wages & Salaries Employer's PAYE & Nl Contributions Pension Contributions Accountancy Fees Legal and Professional Fees (Allowable) Rates & Water Rent Light, Heat & Power Cleaning of Premises General Travel Expenses Bank Charges Advertising General Insurance 53,090 44,633 2,709 3,005 398 1,417 628 650 1,559 799 30,914 3,433 140 30,664 3,432 691 849 110 247 552 1,250 4.346 2,695 9,061 1,883 Computer Expenses Stationery & Postage Telephone, Fax & Internet 5,108 4,931 2,923 14of15
FIBROMYALGIA ACTION UK Detailed Income Statement For the year ended 30 November 2024 Sundry Expenses Trust88s Expenses Donations (Disallowable) Entertainment (Disallowable) Subscriptions 597 (1) 814 807 35 2.876 659 (114,831) 88,264 (103,073) 384,348 Operating profit Profltl(Loss) on ordlnary actlvltles before taxatlon 88,264 384,348 Tax on proflt on ordlnary acllvltlés UK Corporation Tax 579 (579) 87,685 Profltl(Loss) for the flnanclal year 384,348 15of15